01/07/2013 - 2:52pm

You're invited to submit a post for the Sixth Annual Retail Clinician Education Congress. The Retail Clinician Education Congress will be featuring CE break-out sessions and panel discussions on topics submitted by retail clinicians and organizations.

01/07/2013 - 11:49am

Drug maker Prasco Labs has launched an authorized generic version of a drug used to treat heavy menstrual bleeding, the company said.

01/03/2013 - 3:35pm

Par Pharmaceutical Cos. has started shipping two formulations of a generic drug for treating migraines, the company said.

01/03/2013 - 3:25pm

An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

01/03/2013 - 12:31pm

Pfizer's generics division has launched an authorized generic drug for treating epilepsy.

01/03/2013 - 11:39am

Dr. Reddy's Labs has launched a generic drug for treating baldness, the Indian drug maker said.

01/02/2013 - 12:44pm

The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.

01/02/2013 - 12:24pm

The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.

01/02/2013 - 12:21pm

Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets, generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets.